effectiveness of milagu legium for virana silethumam (acute pharyngo-tonsilitis) in children.

An open clinical trial to evaluate the effectiveness of Milagu legium(Internal) for the treatment of Virana silethumam (Acute pharyngo-tonsilitis) in children.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043678

Enrollment

Registered

2022-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J039- Acute tonsillitis, unspecified

Interventions

Intervention1: Milagu Legium: 2gram twice a day with milk Dose vary with age. duration 14 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 5 to 12 years 2. Both Male and Female 3. Throat pain 4. Mild fever 5. Enlarged tonsils

Exclusion criteria

Exclusion criteria: 1. Pneumonia 2. Oral candidiasis 3. Primary complex 4. Congenital cardiac disease 5. Peritonsillar abscess

Design outcomes

Primary

Measure	Time frame
Efficacy of the drug will be assessed by reduction of clinical symptomsTimepoint: Efficacy of the drug will be assessed by reduction of clinical symptoms within 14 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Amala Hazel

National Institute of Siddha Tambaram Sanatorium

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026